Jump to content

Knight Cancer Institute

Edit links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Hannes Röst (talk | contribs) at 14:28, 20 March 2023 (cleanup). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

The OHSU Knight Cancer Institute (previously the OHSU Cancer Institute) is a research institute within Oregon Health & Science University. The National Cancer Institute (NCI) designated cancer center is led by director Brian Druker.[1][2] It is the only NCI-designated Comprehensive Cancer Center in the state of Oregon.[2] The institute is named after Phil Knight and his wife, who donated over $600 million to the center; $100 million in 2008 and $500 million in 2013.[3] The $500 million gift required a matching $500 million, which led to a $100 million donation by Columbia Sportswear chairwoman Gert Boyle in 2014.[4]

History

[edit]

The institute was first designated as a NCI Designated Cancer Center in 1997 and was awarded the status of comprehensive cancer center in 2017.[5] Brian Druker was named the director of the then OHSU Cancer Institute in 2007.[4]

Research areas

[edit]

The Knight Cancer Institute employs over 200 investigators who are affiliated with one of four Cancer Research Programs: Cancer Biology, Cancer Prevention and Control, Quantitative Oncology, and Translational Oncology.[6][7] The Cancer Biology program focuses on tumorigenesis, signal transduction, and the tumor microenvironment.[8] It is led by researchers Mara Sherman and Melissa Wong. Susan Flocke and Kerri Winters-Stone lead the Cancer Prevention and Control research program, which explores cancer prevention and risk reduction, screening and early detection, and survivorship.[9] The Quantitative Oncology program focuses on technology development, molecular characterization, and systems biology.[10] The fourth research program, Translational Oncology, has themes of target validation and high-impact interventions.[11] This program is led by Lara Davis and Jeffrey Tyner.

References

[edit]
  1. ^ "About Us". Oregon Health & Science University. Retrieved 28 June 2017.
  2. ^ a b "Knight Cancer Institute Mission and History | Knight Cancer Institute | OHSU". www.ohsu.edu. Retrieved 2022-01-03.
  3. ^ Theen, Andrew (September 21, 2013). "Phil and Penny Knight to OHSU: $500 million is yours for cancer research if you can match it". The Oregonian/OregonLive. Retrieved 28 June 2017.
  4. ^ a b Budnick, Nick (August 29, 2014). "The story behind Gert Boyle's $100-million gift for cancer research at Oregon Health & Science University". The Oregonian/OregonLive.com. Retrieved June 28, 2017.
  5. ^ "National Cancer Institute Designated Cancer Center". Oregon Health & Science University. Retrieved 28 June 2017.
  6. ^ "Knight Cancer Institute - National Cancer Institute". www.cancer.gov. 2012-07-27. Retrieved 2022-01-03.
  7. ^ "Cancer Research Programs | Knight Cancer Institute | OHSU". www.ohsu.edu. Retrieved 2022-01-03.
  8. ^ "Cancer Biology Research | Knight Cancer Institute | OHSU". www.ohsu.edu. Retrieved 2022-01-03.
  9. ^ "Cancer Prevention and Control Research | Knight Cancer Institute | OHSU". www.ohsu.edu. Retrieved 2022-01-03.
  10. ^ "Quantitative Oncology Research | Knight Cancer Institute | OHSU". www.ohsu.edu. Retrieved 2022-01-03.
  11. ^ "Translational Oncology Research | Knight Cancer Institute | OHSU". www.ohsu.edu. Retrieved 2022-01-03.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Knight_Cancer_Institute&oldid=1145702934"